The immune response to Leishmania: mechanisms of parasite control and evasion
- PMID: 9504340
- DOI: 10.1016/s0020-7519(97)00169-0
The immune response to Leishmania: mechanisms of parasite control and evasion
Abstract
After transmission of Leishmania parasites by sandflies, disease manifestation of the infection requires mechanisms which allow the parasites to replicate in the mammalian host and to resist, at least initially, its innate and acquired antileishmanial defence. Likewise, lifelong persistence of Leishmania parasites, as it occurs even in cases of clinical healing of the infection, points to the existence of strategies which enable the parasite to partially circumvent the protective adaptive immune response of the host. In this review we will discuss the mechanisms which can be invoked to contribute to the initial, as well as long-term, survival of Leishmania parasites in the host organism. These include the passive protection of the parasite against antileishmanial products and the retreat into "safe target cells", the active suppression of the synthesis of reactive oxygen or nitrogen intermediates, the modulation of the host cytokine response, the inhibition of antigen-presentation and T cell-stimulation, and the induction and expansion of counterprotective T helper cells. It is probable that none of these mechanisms alone is sufficient to guarantee the survival of Leishmania, but together they might provide the safe environment which protects the parasite from elimination.
Similar articles
-
Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.J Immunol. 1996 Jun 1;156(11):4318-27. J Immunol. 1996. PMID: 8666803
-
Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination.Autophagy. 2015;11(2):285-97. doi: 10.1080/15548627.2014.998904. Autophagy. 2015. PMID: 25801301 Free PMC article.
-
Leishmania, macrophages and complement: a tale of subversion and exploitation.Parasitology. 1997;115 Suppl:S9-23. doi: 10.1017/s0031182097001789. Parasitology. 1997. PMID: 9571687 Review.
-
Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):102-14. Arch Immunol Ther Exp (Warsz). 2005. PMID: 15928579 Review.
-
Subversion of host cell signalling by the protozoan parasite Leishmania.Parasitology. 2005;130 Suppl:S27-35. doi: 10.1017/S0031182005008139. Parasitology. 2005. PMID: 16281989 Review.
Cited by
-
Anti-leishmania activity of semi-purified fraction of Jacaranda puberula leaves.Parasitol Res. 2007 Aug;101(3):677-80. doi: 10.1007/s00436-007-0530-y. Epub 2007 Mar 28. Parasitol Res. 2007. PMID: 17390147
-
Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.Clin Diagn Lab Immunol. 2000 Mar;7(2):233-40. doi: 10.1128/CDLI.7.2.233-240.2000. Clin Diagn Lab Immunol. 2000. PMID: 10702498 Free PMC article.
-
Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis.Clin Exp Immunol. 2001 May;124(2):262-5. doi: 10.1046/j.1365-2249.2001.01551.x. Clin Exp Immunol. 2001. PMID: 11422203 Free PMC article.
-
Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.J Clin Lab Anal. 2009;23(1):63-9. doi: 10.1002/jcla.20291. J Clin Lab Anal. 2009. PMID: 19140214 Free PMC article.
-
Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major.Infect Immun. 1999 Jun;67(6):3155-9. doi: 10.1128/IAI.67.6.3155-3159.1999. Infect Immun. 1999. PMID: 10338536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical